Repurposing clinically approved drugs for COVID-19 treatment targeting SARS-CoV-2 papain-like protease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Repurposing clinically approved drugs for COVID-19 treatment targeting SARS-CoV-2 papain-like protease

Published:2021-10 Issue: Volume:188 Page:137-146
ISSN:0141-8130
Container-title:International Journal of Biological Macromolecules
language:en
Short-container-title:International Journal of Biological Macromolecules

Author:

Xu Yunxia,Chen Ke,Pan Juanli,Lei Yingshou,Zhang Danting,Fang Lipei,Tang Jinle,Chen Xin,Ma Yanhong,Zheng Yi,Zhang Bao,Zhou Yaoqi,Zhan Jian,Xu Wei

Publisher

Elsevier BV

Subject

Molecular Biology,General Medicine,Biochemistry,Structural Biology

Reference35 articles.

1. The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity;Barretto;J. Virol.,2005

2. From SARS to MERS: crystallographic studies on coronaviral proteases enable antiviral drug design;Hilgenfeld;FEBS J.,2014

3. The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds;Báez-Santos;Antivir. Res.,2015

4. Mechanism and inhibition of the papain-like protease, PLpro, of SARS-CoV-2;Klemm;EMBO J.,2020

5. Interferon-stimulated genes: a complex web of host defenses;Schneider;Annu. Rev. Immunol.,2014

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disrupting protease and deubiquitinase activities of SARS-CoV-2 papain-like protease by natural and synthetic products discovered through multiple computational and biochemical approaches;International Journal of Biological Macromolecules;2024-10

2. Insights for Future Pharmacology: Exploring Phytochemicals as Potential Inhibitors Targeting SARS-CoV-2 Papain-like Protease;Future Pharmacology;2024-08-17

3. Chinese Medicine for Treatment of COVID-19: A Review of Potential Pharmacological Components and Mechanisms;Chinese Journal of Integrative Medicine;2024-07-03

4. Targeting papain-like protease by natural products as novel therapeutic potential SARS-CoV-2;International Journal of Biological Macromolecules;2024-02

5. Targeting SARS-CoV-2 nonstructural protein 3: Function, structure, inhibition, and perspective in drug discovery;Drug Discovery Today;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3